HALISTER: Biotech Investors Bail Out After Gilead’s Drug Pricing Fight

Biotech Investors Bail Out After Gilead’s Drug Pricing Fight

Alert: HALISTER Source: BN (Bloomberg News)

Tickers GILD US (Gilead Sciences Inc) ABBV US (AbbVie Inc) ESRX US (Express Scripts Holding Co)

People Geoffrey Porges (Sanford C Bernstein & Co Inc) Henry Waxman (United States House of Representatives) James Abate (Centre Asset Management LLC) Mark Schoenebaum (Evercore Partners Inc)

Topics Viral Hepatitis

To de-activate this alert, run {NLRT DEACT HALISTER <GO>}. To modify this alert, run {NLRT EDIT HALISTER <GO>}.

UUID: 7947283